The S.K.Offset IPO is a closed SME Bookbuilding offer (Fresh capital only) that opened on 23 September 2026. The S.K.Offset IPO closed on 25 September 2026, with an issue price of ₹125 per share. The S.K.Offset IPO has a face value of ₹10 and a lot size of 1,000 shares. The S.K.Offset IPO size aggregates up to ₹29 crore, listing on BSE SME on 30 September 2026. The S.K.Offset IPO allotment was scheduled for 28 September 2026.
On the financial front, the S.K.Offset IPO reported revenue of ₹67 crore for 31 Mar 2026, compared with ₹49 crore for 31 Mar 2025. The S.K.Offset IPO PAT was ₹7 crore against ₹2 crore. The S.K.Offset IPO EBITDA stood at ₹14 crore with a 21.27% margin. The S.K.Offset IPO net worth as of 31 Mar 2026 was ₹20 crore.
Always verify The S.K.Offset IPO details and GMP data with the official offer document before investing in the S.K.Offset IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
82
56
29
Revenue
67
49
23
PAT
7
2
1
EBITDA
14
6
1
Net Worth
20
7
5
Reserves
14
6
4
Total Borrowing
35
32
15
S.K.Offset IPO Financials FAQs
Revenue of S.K.Offset (Amount in ₹ Crore) — 31 Mar 2026: 67; 31 Mar 2025: 49; 31 Mar 2024: 23. Profit after tax (PAT) — 31 Mar 2026: 7; 31 Mar 2025: 2; 31 Mar 2024: 1.
EBITDA of S.K.Offset (Amount in ₹ Crore) — 31 Mar 2026: 14; 31 Mar 2025: 6; 31 Mar 2024: 1. The EBITDA margin is 21.27%.
Total assets — 31 Mar 2026: 82; 31 Mar 2025: 56; 31 Mar 2024: 29. Net worth — 31 Mar 2026: 20; 31 Mar 2025: 7; 31 Mar 2024: 5. Reserves & surplus — 31 Mar 2026: 14; 31 Mar 2025: 6; 31 Mar 2024: 4. (Amount in ₹ Crore)
Total borrowing of S.K.Offset (Amount in ₹ Crore) — 31 Mar 2026: 35; 31 Mar 2025: 32; 31 Mar 2024: 15. Debt-to-equity ratio: 1.75.
The financials shown for S.K.Offset IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.